Britannia Life Sciences Inc. reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported net income was CAD 0.535316 million compared to net loss of CAD 0.054341 million a year ago.
For the nine months, net income was CAD 1.14 million compared to CAD 4.52 million a year ago. Basic earnings per share from continuing operations was CAD 0.01 compared to CAD 0.03 a year ago.